Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Therapeutic Advances in Medical Oncology|May 31, 2016
Nintedanib in NSCLC: evidence to date and place in therapyGiuseppe Bronte, Francesco Passiglia, Antonio Galvano, et al.
Bioscience Trends|March 18, 2025
Multimodal treatment of colorectal liver metastases: Where are we? Current strategies and future perspectivesCaterina Accardo, Ivan Vella, Fabrizio di Francesco, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Sex steroids, carcinogenesis, and cancer progressionLuigi Castagnetta, Orazia M Granata, Letizia Cocciadiferro, et al.
Proteomes|July 27, 2022
High-Resolution Secretome Analysis of Chemical Hypoxia Treated Cells Identifies Putative Biomarkers of ChondrosarcomaDonatella Pia Spanò, Simone Bonelli, Matteo Calligaris, et al.
Oncotarget|February 27, 2016
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysisFrancesco Passiglia, Giuseppe Bronte, Viviana Bazan, et al.
Expert Opinion on Biological Therapy|February 28, 2013
Monoclonal antibodies in gastrointestinal cancersGiuseppe Bronte, Giuseppe Cicero, Stefania Cusenza, et al.
Critical Reviews in Oncology/Hematology|November 8, 2017
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trialsSergio Rizzo, Antonio Galvano, Francesco Pantano, et al.
Cancer Treatment Reviews|December 7, 2010
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?Sergio Rizzo, Giuseppe Bronte, Daniele Fanale, et al.
Expert Opinion on Biological Therapy|September 12, 2015
Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?Francesco Passiglia, Giuseppe Bronte, Marta Castiglia, et al.
Scientific Reports|September 8, 2018
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysisFrancesco Passiglia, Sergio Rizzo, Massimo Di Maio, et al.
Pageof 7